Autoimmune GFAP astrocytopathy manifesting as sintilimab-induced myelitis: a Case Report and literature review
Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1), programmed cell death protein 1 ligand, and cytotoxic T-lymphocyte-associated protein 4, are important therapeutic approaches for malignancies. However, these novel t…